Clinical Trial Detail

NCT ID NCT02955758
Title Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Joel Neal
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.